ÂÜÀòÂÒÂ×

Andrew Goodearl is a Senior Director at AbbVie Bioresearch Center with extensive experience in the biopharmaceutical industry, focusing on the discovery, research, and early development of biologics drugs. They have previously served as Head of Genetic Medicine Research at AbbVie and held various leadership roles, including Director at Abbott and Associate Director at Millennium Pharmaceuticals. Goodearl's research interests lie in next-generation biologics that act locally in disease tissues. They earned a Ph.D. in Biochemistry from The University of Birmingham and a B.Sc. in Biochemistry from Bristol University.